Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 25,100 shares, a decrease of 12.8% from the April 30th total of 28,800 shares. Based on an average daily trading volume, of 25,800 shares, the days-to-cover ratio is currently […]
Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) saw a large drop in short interest in May. As of May 15th, there was short interest totalling 25,100 shares, a drop of 12.8% from the April 30th total of 28,800 shares. Based on an average daily volume of 25,800 shares, the short-interest ratio is currently 1.0 […]
Equities researchers at Brookline Capital Management assumed coverage on shares of Forte Biosciences (NASDAQ:FBRX – Get Free Report) in a report issued on Thursday, Benzinga reports. The firm set a “buy” rating and a $4.00 price target on the stock. Brookline Capital Management also issued estimates for Forte Biosciences’ Q2 2024 earnings at ($0.16) EPS, […]
Stock analysts at Brookline Capital Management initiated coverage on shares of Forte Biosciences (NASDAQ:FBRX – Get Free Report) in a note issued to investors on Thursday, Benzinga reports. The brokerage set a “buy” rating and a $4.00 price target on the stock. Brookline Capital Management also issued estimates for Forte Biosciences’ Q2 2024 earnings at […]
Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock traders acquired 30,205 call options on the company. This represents an increase of 1,663% compared to the typical volume of 1,713 call options. Forte Biosciences Trading Up 2.5 % Shares of FBRX stock opened at […]